TUL regards innovative R&D as a core engine driving corporate development. The company continuously increases investment in research, recruits scientific talent, and expands its innovation pipeline through diversified models such as independent development and collaborative projects. This strategic approach enhances its drug development and clinical research capabilities, accelerating the R&D and practical applications of the innovative technologies and products.
100
+
- Ongoing R&D Projects
100
+
- Patents Granted
986
million
- R&D Investment (2024)
1000
+
- R&D and Technical Staff
*Data as of March 2025